Chronic Dosing of Apricot Kernel Extract May Lead to Hypoxia

This article originally appeared here.
Share this content:
Chronic Dosing of Apricot Kernel Extract May Lead to Hypoxia
Chronic Dosing of Apricot Kernel Extract May Lead to Hypoxia

TUESDAY, Sept. 12, 2017 (HealthDay News) -- Chronic dosing of apricot kernel extract can result in hypoxia and cyanide toxicity, according to a report published online Sept. 11 in BMJ Case Reports.

Alex Konstantatos, M.B.B.S., from Alfred Hospital in Melbourne, Australia, and colleagues describe the case of a 67-year-old man who appeared hypoxic with peripheral pulse oximetric measurement during routine anesthesia.

The authors note that the patient admitted self-prescription of apricot kernel extract daily for five years. Apricot kernel is associated with cyanide toxicity, which was confirmed in blood analysis. The presence of free cyanide was thought to interfere with functioning of the peripheral pulse oximeter resulting in hypoxic measurement. Peripheral oxygen saturations returned to normal on cessation of apricot kernel extract. The authors excluded cardiac and respiratory causes, and rare hemoglobinopathies.

"This case illustrates how chronic dosing of complementary medicines can result in harmful toxicities, which may carry potential for serious consequences and how these chronic toxicities may present to physicians in atypical ways," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Doctors Urged to Speak With Patients About Firearms

Doctors Urged to Speak With Patients About Firearms

Making a public commitment is encouraged as a positive action that physicians can take

Machine Learning Model Predicts Risk of Upgrade to Breast CA

Machine Learning Model Predicts Risk of Upgrade to ...

Model can predict risk of upgrade of high-risk breast lesions to cancer using traditional, text features

Glycemic Control Up With Oral Semaglutide in Type 2 Diabetes

Glycemic Control Up With Oral Semaglutide in Type ...

Phase 3 studies next to assess longer-term/clinical outcomes, safety

is free, fast, and customized just for you!

Already a member?

Sign In Now »